T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cigna
CI
$73.3B
| $3.92B | 0.57% |
13,712,837
-144,807
| -1% | -$41.3M |
|
27
Roper Technologies
ROP
$39.1B
| $3.92B | 0.57% |
8,093,611
-77,529
| -0.9% | -$38M |
|
|
28
SLB Ltd
SLB
$78.1B
| $3.89B | 0.57% |
66,761,877
+42,824,486
| +179% | +$2.48B |
|
29
Booking.com
BKNG
$159B
| $3.87B | 0.57% |
31,349,150
-2,772,525
| -8% | -$336M |
|
30
Berkshire Hathaway Class B
BRK.B
$1.09T
| $3.77B | 0.55% |
10,773,716
-178,493
| -2% | -$63.3M |
|
31
Danaher
DHR
$145B
| $3.72B | 0.54% |
16,898,303
+1,132,440
| +7% | +$253M |
|
32
Procter & Gamble
PG
$335B
| $3.64B | 0.53% |
24,976,555
-555,212
| -2% | -$84.8M |
|
33
AstraZeneca
AZN
$246B
| $3.64B | 0.53% |
26,872,344
+449,545
| +2% | +$61.4M |
|
34
Humana
HUM
$46.7B
| $3.45B | 0.5% |
7,082,019
-143,739
| -2% | -$67.5M |
|
35
Becton Dickinson
BDX
$50B
| $3.33B | 0.49% |
12,892,427
-1,348,554
| -9% | -$364M |
|
36
Stryker
SYK
$133B
| $3.25B | 0.48% |
11,899,667
-388,366
| -3% | -$111M |
|
37
Salesforce
CRM
$158B
| $3.12B | 0.46% |
15,397,261
+226,969
| +1% | +$49M |
|
38
Wells Fargo
WFC
$269B
| $3.11B | 0.46% |
76,110,979
-9,614,158
| -11% | -$415M |
|
39
ASML
ASML
$695B
| $3.08B | 0.45% |
5,233,950
-663,285
| -11% | -$441M |
|
40
Philip Morris
PM
$290B
| $3.04B | 0.45% |
32,803,593
-1,708,695
| -5% | -$164M |
|
41
Accenture
ACN
$110B
| $3.03B | 0.44% |
9,878,333
-1,956,277
| -17% | -$616M |
|
42
Merck
MRK
$328B
| $3.01B | 0.44% |
29,278,165
-112,224
| -0.4% | -$12.1M |
|
43
Adobe
ADBE
$103B
| $3.01B | 0.44% |
5,906,799
+1,558,612
| +36% | +$818M |
|
44
Walmart Inc
WMT
$923B
| $2.89B | 0.42% |
54,256,707
+784,713
| +1% | +$41.8M |
|
|
45
Johnson & Johnson
JNJ
$629B
| $2.88B | 0.42% |
18,462,122
-9,453,413
| -34% | -$1.56B |
|
|
SCHW
46
Charles Schwab
SCHW
$189B
| $2.85B | 0.42% |
51,991,142
+15,222,707
| +41% | +$920M |
|
47
Ross Stores
ROST
$79.6B
| $2.64B | 0.39% |
23,392,882
-3,058,076
| -12% | -$351M |
|
48
Qualcomm
QCOM
$171B
| $2.6B | 0.38% |
23,427,471
+4,607,890
| +24% | +$535M |
|
|
49
Advanced Micro Devices
AMD
$788B
| $2.58B | 0.38% |
25,122,292
-15,248,537
| -38% | -$1.66B |
|
50
Chevron
CVX
$386B
| $2.58B | 0.38% |
15,306,508
-74,301
| -0.5% | -$12M |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.